4//SEC Filing
Primiano Christopher Brett 4
Accession 0001209191-20-056883
CIK 0001503802other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:09 PM ET
Size
5.0 KB
Accession
0001209191-20-056883
Insider Transaction Report
Form 4
Primiano Christopher Brett
VP, Gen Counsel & Secretary
Transactions
- Sale
Common Stock
2020-11-02$14.92/sh−772$11,518→ 4,523 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001603510
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:09 PM ET
- Size
- 5.0 KB